Clinical Trial Update: Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients [Phase 4]

View source ↗

Summary

A completed Phase 4 trial comparing the effect and safety of clopidogrel napadisilate versus clopidogrel bisulfate in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Clopidogrel Napadisilate (clopidogrel napadisilate)
• Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Coronary Artery Disease (CAD) | Phase 4 | Status: COMPLETED